(S)-Mirtazapine-d3

• CAT Number: S000485
• Molecular Formula: C17H16D3N3
• Molecular Weight: 268.37
• Purity: ≥95%
• Target: Neuronal Signaling
• IUPAC Name: (7S)-5-(trideuteriomethyl)-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene
• InChI: InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3/t16-/m1/s1/i1D3
• InChIKey: RONZAEMNMFQXRA-JOTALGBPSA-N
• SMILES: CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4

(S)-Mirtazapine-d3（Cat No.:S000485） is a deuterated form of the (S)-enantiomer of mirtazapine, where three hydrogen atoms are replaced with deuterium. Mirtazapine is an antidepressant medication known for its dual action of enhancing noradrenergic and serotonergic activity. It is primarily used to treat major depressive disorder and has additional benefits like improving sleep and appetite. The inclusion of deuterium in (S)-Mirtazapine-d3 increases molecular stability, which is advantageous for conducting pharmacokinetic and metabolic studies.